...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Percutaneous thrombolysis and stent placement for the treatment of portal vein thrombosis after liver transplantation: long-term follow-up.
【24h】

Percutaneous thrombolysis and stent placement for the treatment of portal vein thrombosis after liver transplantation: long-term follow-up.

机译:经皮溶栓和支架置入术治疗肝移植后门静脉血栓形成:长期随访。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: The durable use of percutaneous minimally invasive techniques for the treatment of portal venous thrombosis after liver transplant has not been widely described. This report illustrates two cases in which percutaneous thrombolysis, angioplasty, and endovascular stent placement were successfully used to treat portal vein thrombosis in patients with recent liver transplants. METHODS: Liver dysfunction was initially manifested by the elevation of liver enzymes or the development of marked ascites and confirmed in both cases by sonography and angiography. The occluded portal vein was accessed by either a transjugular transhepatic puncture or direct transhepatic catheterization. Intraportal thrombolytic infusion, angioplasty, and stent placement were accomplished without complication. RESULTS: At the most recent follow-up, portal vein patency had been maintained for 2.5 and 4.5 years. CONCLUSIONS: These results demonstrate the technical feasibility and long-term patency of angioplasty and endovascular stent placement for the treatment of portal vein thrombosis in liver transplant recipients.
机译:背景:肝移植后经皮微创技术在治疗门静脉血栓中的持久使用尚未得到广泛描述。该报告说明了两个案例,其中经皮溶栓,血管成形术和血管内支架置入成功用于治疗近期肝移植患者的门静脉血栓形成。方法:肝功能异常最初表现为肝酶升高或出现明显的腹水,并通过超声和​​血管造影证实。经颈静脉经肝穿刺或直接经肝穿刺可进入阻塞的门静脉。门静脉内溶栓,血管成形术和支架置入均无并发症。结果:在最近的随访中,门静脉通畅性维持了2.5和4.5年。结论:这些结果证明了血管成形术和血管内支架置入技术治疗肝移植受者门静脉血栓形成的技术可行性和长期通畅性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号